• Home
  • YSK Laboratories Pvt Ltd

YSK Laboratories Pvt Ltd

About YSK Laboratories Pvt Ltd

We are an R&D Company with a Vision to Develop Technologies for Better Finished Formulations. YSK produces “SMART APIs” in Semi-Formulated form that can be Directly Compressed into Solid Finished Dosage Forms (Tablets) in only ONE step of Compression. These Directly Compressible Granules (DC Granules) offer multiple advantages. We offer Superior Quality Sustained/Extended Release and Immediate Release Products which are Unique in terms of their Manufacturing Technologies, Higher Active Ingredient Content and Lower Excipient load. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IN
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
  • +919821249997
  • Website
  • 83 E Hansraj pragii Building,, 1st Floor, L Pappan Marg, Off Dr E Moses Road, 400018, Mumbai, Maharashtra, India
Show contact info Hide contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

CPHI Middle East 2024

Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
10 Dec 2024 - 12 Dec 2024
View Exhibitor Profile

Products from YSK Laboratories Pvt Ltd (3)

  • Directly Compressible (DC) Granules Product List

    Product Directly Compressible (DC) Granules Product List

    Aceclofenac Granules = 48% Amlodipine Granules = 66.70% Clopidogrel Granules = 48% Fexofenadine Granules = 25.30% Gliclazide SR Granules = 25.30% Levetiracetam SR Granules = 7.10% Lisinopril Granules = 12.5%, 16% Montelukast Granules = 50% Paracetamol Granules = 83%, 90%, 96% Sildenafil Citrate Granules = ...
  • Metformin DC Granules

    Product Metformin DC Granules

    Immediate Release = 86.66% and 95% Sustained Release = 75% and 80%
  • Directly Compressible Granules

    Product Directly Compressible Granules

    1. Aceclofenac Granules 50%2. Clopidogrel Granules 60%
    3. Fexofenadine Granules 48%
    4. Gliclazide Granules SR 48%
    5. Levitiracetam Granules SR 75%, 80%
    6. Lisinopril Granules 50%
    7. Metformin HCL Granules IR 86.66%, 93%
    8. Metformin HCL Granules SR 75%, 80%
    9. Montelukast Granules 7.1%...

YSK Laboratories Pvt Ltd Resources (2)

  • YSK Labs - CCD partners Watchlist 2023

    News YSK Labs - CCD partners Watchlist 2023

    YSK Labs was featured on the CCD partners Watchlist 2023 aimed to highlight the profile of Innovative and disruptive Startup companies participating in the CPHI Startup Market 2023. This Watchlist is designed to capture and track exciting up-and-coming businesses with the potential to disrupt the pharmaceutical industry. 

    Out of approximately 1000+ companies in over 57 countries, YSK Labs was amongst the 21 companies selected and featured. 
    14 Sep 2023
  • YSK Brochure 1

    Brochure YSK Brochure 1